Ipragliflozin improves hepatic steatosis in obese mice and liver dysfunction in type 2 diabetic patients irrespective of body weight reduction

Chikara Komiya, Kyoichiro Tsuchiya, Kumiko Shiba, Yasutaka Miyachi, Shunsaku Furuke, Noriko Shimazu, Shinobu Yamaguchi, Kazuo Kanno, Yoshihiro Ogawa

研究成果: Contribution to journalArticle

88 引用 (Scopus)

フィンガープリント Ipragliflozin improves hepatic steatosis in obese mice and liver dysfunction in type 2 diabetic patients irrespective of body weight reduction' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

Medicine & Life Sciences

Agriculture & Biology

Chemical Compounds